The Generalized Anxiety Disorder 7-item scale (GAD-7) is the most widely used anxiety screening tool in clinical practice. Developed by Spitzer, Kroenke, Williams, and Löwe in 2006 and published in Archives of Internal Medicine, it provides validated, standardized measurement of anxiety severity in just seven questions covering the past two weeks.
Understanding GAD-7 scoring helps patients engage more effectively with their care. The original validation study in over 2,700 primary care patients established psychometric properties that have been replicated in dozens of subsequent studies.
What the GAD-7 Measures
The GAD-7 asks how often, over the past 2 weeks, you’ve been bothered by:
- Feeling nervous, anxious, or on edge
- Not being able to stop or control worrying
- Worrying too much about different things
- Trouble relaxing
- Being so restless that it’s hard to sit still
- Becoming easily annoyed or irritable
- Feeling afraid as if something awful might happen
Each item is scored 0-3 (not at all, several days, more than half the days, nearly every day). Total score ranges from 0 to 21.
Score Interpretation
Per the original Spitzer et al. (2006) validation and subsequent research:
- 0-4: Minimal anxiety — typically no treatment needed
- 5-9: Mild anxiety — monitoring; sometimes intervention
- 10-14: Moderate anxiety — treatment generally warranted
- 15-21: Severe anxiety — treatment typically essential
Psychometric Properties
The original validation study (Spitzer et al., 2006) established that a GAD-7 score of 10 or higher has approximately 89% sensitivity and 82% specificity for generalized anxiety disorder when compared against structured clinical interview. Subsequent meta-analyses have replicated these findings across populations.
Importantly, the GAD-7 was originally developed to screen for GAD specifically, but Kroenke et al. (2007) demonstrated that it also performs well as a screener for panic disorder, social anxiety disorder, and PTSD in primary care settings — making it useful as a general anxiety screening instrument.
What GAD-7 Is Good For
Initial screening
Identifies patients who may have clinically significant anxiety requiring further evaluation. The 10+ threshold is the standard clinical action point.
Severity assessment
Provides standardized measure of severity at point of evaluation — supporting treatment decisions.
Treatment tracking
Repeating the GAD-7 at intervals shows treatment response. A reduction of 5 or more points typically represents meaningful clinical improvement. Many practices repeat GAD-7 every 4-8 weeks during active treatment.
Measurement-based care
Systematic GAD-7 use as part of measurement-based care has been associated with improved outcomes in meta-analyses — typically a 17-40% improvement over treatment-as-usual approaches.
Free and accessible
The GAD-7 is in the public domain, free to use, and available in many languages — making it broadly accessible.
What GAD-7 Is Not Good For
Definitive diagnosis
A high score suggests anxiety; it doesn’t make a diagnosis. Clinical evaluation considers GAD-7 alongside history, examination, and other information.
Distinguishing anxiety subtypes
GAD-7 doesn’t reliably distinguish generalized anxiety from panic disorder, social anxiety, or PTSD. Different conditions may produce similar scores.
Detecting some anxiety presentations
Specific phobia, social anxiety limited to specific situations, and some other anxiety presentations may produce relatively normal scores despite significant impairment.
Cultural variation
Some patients underreport on standardized scales due to stigma or cultural factors. Clinical context matters.
Using GAD-7 in Treatment
Baseline measurement
Establishing GAD-7 at start of treatment provides baseline for comparison.
Tracking response
Repeating at intervals (typically every 4-8 weeks during active treatment) shows progress.
Adjustment trigger
If less than 50% reduction at 8 weeks, treatment intensification typically warranted — dose adjustment, augmentation, or switching strategies.
Remission goal
Treatment goal is typically GAD-7 score below 5 (minimal anxiety range) — full remission, not just response.
Source: Spitzer et al. (2006), Arch Intern Med; subsequent meta-analyses.
Subjective tracking only
Anxiety treatment without standardized measurement often misses subtle progress or persistent symptoms.
Measurement-based care
Dr. Farkas uses validated scales like GAD-7 to track treatment response objectively — informing intervention decisions.
Documented improvement
Standardized tracking ensures treatment is producing measurable response — and adjustments happen when it isn’t.
Common Questions About GAD-7
Is GAD-7 the same as a diagnosis?
No. A high score suggests anxiety warranting evaluation; diagnosis requires clinical assessment considering history, examination, differential diagnosis, and other factors. The GAD-7 is a screening and tracking instrument, not a diagnostic test.
Can I trust online GAD-7 tests?
The GAD-7 itself is a reliable, validated instrument and is in the public domain. Self-administration is appropriate for self-awareness. Treatment decisions require professional evaluation.
What if I score high but feel fine?
Worth discussing with a clinician. Sometimes scores capture symptoms patients have normalized over time. See our related articles on anxiety disorders and high-functioning anxiety.
How often should GAD-7 be repeated?
During active treatment, every 4-8 weeks is typical. Less frequently during maintenance phase. Some research supports more frequent (session-by-session) measurement as part of measurement-based care.